ACTIVE

Den Baksteen

Export PDF

Financial year 2026 · closed on 31/03/2026

Net result

38,6 k €

-14.0% YoY

Gross margin

107,6 k €

-4.4% YoY

Equity

579,5 k €

+7.1% YoY

What does Den Baksteen do?

Den Baksteen is a Public limited company incorporated in 1990. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Asse.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0441.068.601

Incorporation

07/08/1990

Legal form

Public limited company

Registered office

Louwijn 33
1730 Asse · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/03/2026

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2026		2025		2024		2023		2022		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	107,6 k €	-4.4%	112,6 k €	+9.2%	103,1 k €	+2.8%	100,2 k €	+383%	20,8 k €	-83.0%	122,2 k €	+29.6%	94,3 k €	+19.3%	79 k €	-12.8%	90,6 k €	+35.9%	66,7 k €	-9.4%	73,6 k €	+25.9%	58,5 k €	+20.2%	48,7 k €	-37.0%	77,2 k €	+28.6%	60 k €	+22.1%	49,1 k €
EBITDA	112,9 k €	+1.3%	111,4 k €	+13.8%	97,9 k €	+2.5%	95,5 k €	+546%	14,8 k €	-87.7%	120,5 k €	+53.0%	78,8 k €	+40.1%	56,2 k €	-27.1%	77,2 k €	+19.5%	64,6 k €	-7.2%	69,6 k €	+66.3%	41,8 k €	+118%	19,2 k €	-60.0%	48,1 k €	+45.7%	33 k €	-4.1%	34,4 k €
Operating result	62,8 k €	+3.4%	60,7 k €	+35.6%	44,8 k €	-6.4%	47,9 k €	+532%	-11,1 k €	-110%	115,3 k €	+69.2%	68,1 k €	+51.4%	45 k €	-23.7%	58,9 k €	+27.3%	46,3 k €	-10.1%	51,5 k €	+94.7%	26,4 k €	+761%	3,1 k €	-91.4%	35,6 k €	+75.2%	20,3 k €	-16.3%	24,3 k €
Net result	38,6 k €	-14.0%	44,9 k €	+52.1%	29,5 k €	-4.6%	31 k €	+428%	-9,4 k €	-113%	73 k €	+71.3%	42,6 k €	+21.9%	35 k €	-29.6%	49,7 k €	+35.7%	36,6 k €	-21.1%	46,4 k €	+63.5%	28,4 k €	+335%	6,5 k €	-77.9%	29,6 k €	+73.3%	17,1 k €	-23.9%	22,4 k €
Balance sheet
Equity	579,5 k €	+7.1%	540,9 k €	+1.2%	534,4 k €	+3.3%	517,4 k €	+6.4%	486,4 k €	+0.1%	485,7 k €	-0.0%	485,8 k €	+9.6%	443,2 k €	+8.6%	408,2 k €	+2.7%	397,6 k €	+10.1%	361 k €	+9.8%	328,6 k €	+5.6%	311,3 k €	+0.8%	308,8 k €	+9.0%	283,2 k €	+4.8%	270,2 k €
Total assets	1,7 M €	-1.3%	1,8 M €	-2.2%	1,8 M €	+4.0%	1,7 M €	+0.5%	1,7 M €	+175%	625 k €	+12.5%	555,6 k €	+6.1%	523,7 k €	-27.9%	725,9 k €	+49.6%	485,2 k €	+1.9%	475,9 k €	+7.8%	441,4 k €	+0.5%	439,3 k €	+9.5%	401,4 k €	+10.1%	364,6 k €	+2.3%	356,5 k €
Cash	14,6 k €	-65.1%	41,8 k €	+9.8%	38,1 k €	+211%	12,2 k €	-54.0%	26,6 k €	-86.2%	192,9 k €	+21.5%	158,7 k €	+3.4%	153,4 k €	-56.2%	349,9 k €	+179%	125,4 k €	+11.6%	112,4 k €	-15.0%	132,2 k €	+0.9%	131 k €	-1.3%	132,7 k €	+44.6%	91,8 k €	+25.1%	73,4 k €
Debts	1,1 M €	-4.6%	1,2 M €	-3.1%	1,2 M €	+5.2%	1,2 M €	-1.3%	1,2 M €	+741%	139,3 k €	+99.5%	69,8 k €	-13.3%	80,6 k €	-74.6%	317,7 k €	+263%	87,6 k €	-23.8%	114,9 k €	+1.9%	112,8 k €	-11.9%	128 k €	+38.3%	92,6 k €	+13.8%	81,3 k €	-5.8%	86,3 k €
Other
Workforce	–		–		–		–		–		–		0,3 ETP	-25.0%	0,4 ETP	0.0%	0,4 ETP		–		–		0,4 ETP	-33.3%	0,6 ETP	0.0%	0,6 ETP	-14.3%	0,7 ETP	+75.0%	0,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2026 · 1 active · 11 ended

Active mandates

FARMADIL

Gedelegeerd bestuurder · since 31 août 2017 · 0874.566.252

Represented by Bruno De Luyck

Active

Ended mandates

FARMADIL

Gedelegeerd bestuurder · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

FARMADIL

Managing director · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

FARMADIL

Managing director · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

Farmadil BV

Gedelegeerd bestuurder · since 31 août 2017 · until 31 août 2023

Represented by Bruno De Luyck

Ended

At this address

Other companies at this address

Company	CBE no.
FARMADIL● Active	0874.566.252
pills for nature● Active	0733.805.691

Annual accounts

Full financial information

	2026	2025	2024	2023	2022	2021
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2025	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020
Closing of the financial year	31/03/2026	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2026	15/07/2025	28/06/2024	19/07/2023	06/07/2022	27/07/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	05/06/2023	07/06/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2026	01/06/2026	14/07/2026	Dutch	PDF
Abridged model	31/03/2025	02/06/2025	15/07/2025	Dutch	PDF
Abridged model	31/03/2024	03/06/2024	28/06/2024	Dutch	PDF
Abridged model	31/03/2023	05/06/2023	19/07/2023	Dutch	PDF
Abridged model	31/03/2022	07/06/2022	06/07/2022	Dutch	PDF
Abridged model	31/03/2021	07/06/2021	27/07/2021	Dutch	PDF
Abridged model	31/03/2020	02/06/2020	26/06/2020	Dutch	PDF
Abridged model	31/03/2019	20/09/2019	22/10/2019	Dutch	PDF
Abridged model	31/03/2018	04/06/2018	30/07/2018	Dutch	PDF
Abridged model	31/03/2017	05/06/2017	29/06/2017	Dutch	PDF
Abridged model	31/03/2016	06/06/2016	27/07/2016	Dutch	PDF
Abridged model	31/03/2015	01/06/2015	30/09/2015	Dutch	PDF
Abridged model	31/03/2014	02/06/2014	30/09/2014	Dutch	PDF
Abridged model	31/03/2013	03/06/2013	07/08/2013	Dutch	PDF
Abridged model	31/03/2012	04/06/2012	28/09/2012	Dutch	PDF
Abridged model	31/03/2011	06/06/2011	30/07/2011	Dutch	PDF
Abridged model	31/03/2010	07/06/2010	30/07/2010	Dutch	PDF
Abridged model	31/03/2009	01/06/2009	07/07/2009	Dutch	PDF
Abridged model	31/03/2008	04/08/2008	19/09/2008	Dutch	PDF
Abridged model	31/03/2007	06/08/2007	05/09/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2026 · 1 active · 11 ended

Active mandates

FARMADIL

Gedelegeerd bestuurder · since 31 août 2017 · 0874.566.252

Represented by Bruno De Luyck

Active

Ended mandates

FARMADIL

Gedelegeerd bestuurder · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

FARMADIL

Managing director · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

FARMADIL

Managing director · since 31 août 2017 · until 31 août 2023 · 0874.566.252

Represented by Bruno De Luyck

Ended

Farmadil BV

Gedelegeerd bestuurder · since 31 août 2017 · until 31 août 2023

Represented by Bruno De Luyck

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring01/09/2026
Partiële splitsing
PDF
Mandates15/01/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Restructuring12/08/2020
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates29/09/2017
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares25/07/2017
KAPITAAL - AANDELEN
PDF
Capital / shares07/04/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates22/09/2011
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/10/2005
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2026
Annual accounts 202638,6 k €↓
2025
Annual accounts 202544,9 k €↑
2024
Annual accounts 202429,5 k €↓
2023
Annual accounts 202331 k €↑
2022
Annual accounts 2022-9,4 k €↓
2021
Name changeDen Baksteen
2017
Annual accounts 201773 k €↑
2016
Annual accounts 201642,6 k €↑
2015
Annual accounts 201535 k €↓
2014
Annual accounts 201449,7 k €↑
2013
Annual accounts 201336,6 k €↓
2012
Annual accounts 201246,4 k €↑
2011
Annual accounts 201128,4 k €↑
2010
Annual accounts 20106,5 k €↓
2009
Annual accounts 200929,6 k €↑
2008
Annual accounts 200817,1 k €↓
2007
Annual accounts 200722,4 k €
2007
Name changeBI - FAR
07/08/1990
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Den Baksteen

Overview

What does Den Baksteen do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline